Who Paid My Doc Search
Menu
Organisation paid for research Program year 2021 Source: CMS Open Payments

WCCT Global, LLC

Neither a doctor nor a teaching hospital

Research payments

$6,913,470

13 payments

Through program year 2021, WCCT Global, LLC is reported as receiving $6,913,470 in research payments, across 13 payments.

By program year

3 rows
Year Kind Amount Payments
2021 Research $3,125 1
2020 Research $3,022,088 4
2019 Research $3,888,257 8

Breakdown

Who paid Research payments · program years 2019–2021
  1. Amphastar Pharmaceuticals, Inc. $5,107,244 10 payments
  2. E.R. Squibb & Sons, L.L.C. $1,806,226 3 payments
Studies the money was for Research payments · program years 2019–2021
  1. An Open-Label, Active-Controlled, Single Ascending Dose Study to Initially Investigate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Intranasal (IN) Epinephrine (E005) in Healthy Volunteers $1,327,655 1 payment
  2. Pharmacokinetics Bioequivalence Study of Beclomethasone Dipropionate HFA MDI (Q001, 40 mcg/inhalation) versus QVAR Inhalation Aerosol (40 mcg/inhalation) and QVAR REDIHALER mcg/inhalation) in Healthy Adult Volunteers $1,239,726 1 payment
  3. OC DDI (clinical drug interaction study) $997,622 1 payment
  4. The Effect of BMS-986256 on the Pharmacokinetics of a Combined Oral Contraceptive (Ethinyl Estradiol/Norethindrone) in Healthy Female Participants $808,605 2 payments
  5. Pharmacokinetics Bioequivalence Study of Beclomethasone Dipropionate HFA MDI (Q001, 80 mcg/inhalation) versus QVAR Inhalation Aerosol (80 mcg/inhalation) in Healthy Adult Volunteers $767,421 1 payment
  6. Pharmacokinetics (PK) Bioequivalence (BE) Study of Albuterol Sulfate HFA MDI 90 mcg/inhalation (A008) versus ProAir HFA Inhalation Aerosol 90 mcg/inhalation in Healthy Adult Volunteers $622,932 1 payment
  7. Bioequivalence (BE) Pharmacokinetics (PK) Study of Iron Sucrose Injection by Intravenous Infusion in Healthy Adult Volunteers $374,675 1 payment
  8. Pharmacokinetic (PK) Study of Intranasal (IN) Naloxone HCl (N002) in Healthy Adult Volunteers: Influence of Runoff Volume on Partial AUC $302,158 1 payment
  9. Study of Drug Exposure in Systemic Circulation of Primatene Mist (0.25mg) by Oral Inhalation, versus Epinephrine Injection (0.30mg) by IM and ProAir (0.18mg) by Oral Inhalation in Healthy Individuals $266,022 1 payment
  10. Study of Drug Exposure in Systemic Circulation of Primatene Mist (0.50mg) by Oral Inhalation, versus Epinephrine Injection (0.30mg) by IM and ProAir (0.18mg) by Oral Inhalation, in Healthy Individuals $193,551 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record